The National Initiative for RNA Biology and its Applications (NIRBA) has officially opened its new Hub at the National U...
Devonian Health Group has received Health Canada authorisation to initiate a Phase II/III paediatric clinical trial of P...
US-based BostonGene, the developer of the leading AI model for tumour and immune biology, has announced a strategic...
The Ministry of Health and Welfare (MoHW), South Korea, and Novartis have signed a Memorandum of Understanding (MoU) und...
The Chinese University of Hong Kong (CUHK); the People’s Government of Nansha District, Guangzhou; and Guangzhou F...
ING has examined the shifting global pharmaceutical landscape in a podcast discussion focused on China’s biotech b...
Tikva Allocell, a Singapore-based biotechnology startup developing engineered, allogeneic (donor-derived) cell therapies...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
A “precision guided” CAR T-cell therapy designed at Peter MacCallum Cancer Centre, Australia’s on...
Antibody-drug conjugates, GLP-1, dementia. Three Special Forums at BIO Asia-Taiwan 2026, three unrelated areas of medici...
On Wednesday the keynote argued that when AI compresses discovery, the constraint simply relocates: to manufacturing, ca...
Taiwan’s ambition to become one of Asia’s most consequential biotechnology hubs received a powerful ...
The Hong Kong University of Science and Technology (HKUST) and the Ministry of Higher Education, Science, and Technology...
BIOSPECTRUM ASIA · DAY TWO ROUND-UP Day 1 belonged to the plenaries and the press. Day 2 was when ...
The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 2.86 billion (...
A CEPI-backed vaccine candidate developed by the University of Oxford’s Oxford Vaccine Group has become the first ...
Delonix Bioworks has dosed the first participant in its Phase 1 clinical trial of DX-104, a next-generation Group B meni...
Cervical cancer is largely preventable, yet it continues to place a disproportionate burden on women across Asia. The re...
US-based GEM Global Yield LLC SCS has executed a Share Purchase Agreement (SPA) with the existing shareholders of Taiwan...
South Korea-based startup Boostimmune has secured a Japanese patent covering technology that uses antibodies to inhibit ...
ARIA Bioscience, Singapore’s longevity biotech commercialisation firm, is collaborating with the A*STAR Institute ...
South Korea-based Samsung Bioepis has entered into a license agreement with Proteina Co. to collaborate on a government-...
India's Godavari Biorefineries has been granted a patent by the Japan Patent Office for its breakthrough invention, "5-H...
Australian biotech Aegros has completed Australia’s second human plasma fractionation facility, joining CSL’...
Seegene has announced the launch of the Global Million Clinical Study (GMCS), aiming to evaluate the clinical utility an...
